The Pentagon Has a Hard Deadline. There Are Only Two Companies That Can Meet It.
A January 2027 ban on Chinese rare earth magnets just became the most overlooked supply shock in defense history.
A January 2027 ban on Chinese rare earth magnets just became the most overlooked supply shock in defense history.
McDonald’s is invading Starbucks’ turf. One stock is priced for it. The other is not.
A Q2 delivery beat and Fitch upgrade have the stock moving. Free cash flow is the real test.
The turnaround is real but slow. China is the problem nobody has solved yet.
XLV is leading, but not every part of healthcare is going the same direction.
Quantinuum went public. Now the real question is which quantum stock deserves your money.
A $1.1B program aimed at 300,000 one-way drones by 2027, Phase II testing at Camp Grayling, and the strategic-capital budget math traders are watching.
NuScale just hit a new near-term high after the HIPS safety contract. The TVA program, the $1B liquidity runway, and a wildly volatile options structure are the real story.
Q2 revenue up 196% year-over-year. HBM sold out through 2026. Wall Street is racing to raise targets. The story is more structural than most realize.
A $63 billion backlog and a power generation arm tied to AI data centers are rewriting what CAT actually is.